You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasmodium falciparum

Showing 1 - 25 of 837
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malaria,Falciparum, Malaria, Vivax, Malaria Trial in Manokwari (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Malaria,Falciparum
  • +5 more
  • Manokwari, West Papua, Indonesia
    Manokwari Regional General Hospital
Sep 11, 2023

Malaria Trial (Meplazumab for Injection)

Not yet recruiting
  • Malaria
  • Meplazumab for Injection
  • (no location specified)
Sep 13, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
Feb 17, 2023

Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)

Recruiting
  • Malaria
  • Plasmodium Falciparum
  • Pfs48/45 in Matrix-M
  • Oxford, United Kingdom
    CCVTM, University of Oxford
Dec 13, 2022

Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria Trial (ZY19489 + Ferroquine (FQ), Placebo)

Not yet recruiting
  • Uncomplicated Malaria
  • +2 more
  • ZY19489 + Ferroquine (FQ)
  • Placebo
  • (no location specified)
Jun 18, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-lumefantrine and Amodiaquine Drug Combination
  • +2 more
  • Bagamoyo, Dar esSalaam, Tanzania
  • +1 more
Feb 28, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (KLU156, Coartem)

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
May 3, 2023

Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Uncomplicated Plasmodium Falciparum
  • Tambolaka, East Nusa Tenggara, Indonesia
    Kori Puskesmas
Apr 27, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-Lumefantrine-Amodiaquine (ALAQ)
  • +2 more
  • (no location specified)
Jul 20, 2023

Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)

Not yet recruiting
  • Malaria Infection
  • M5717 60 mg
  • +4 more
  • Darmstadt, Germany
    Research Site
Aug 2, 2023

Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)

Not yet recruiting
  • Plasmodium Falciparum Malaria
  • DHA/piperaquine and a SLD-PQ
  • Study vaccine R21/Matrix-M™
  • Bāndarban, Bangladesh
  • +1 more
Sep 28, 2023

TES of Artemether-lumefantrine for Pf in the Philippines in 2015

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

TES of Artemether-lumefantrine for Pf in Philippines in

Completed
  • Malaria,Falciparum
  • Malaria Recrudescence
  • (no location specified)
Jul 20, 2023

Plasmodium Falciparum Antimalarial Drug Resistance Markers

Completed
  • Plasmodium Falciparum
    • Kome, Doba, Chad
      Study clinic
    Mar 29, 2022

    Malaria, Plasmodium Falciparum Trial in Bagamoyo (P. falciparum infected erythrocytes)

    Not yet recruiting
    • Malaria
    • Plasmodium Falciparum
    • P. falciparum infected erythrocytes
    • Bagamoyo, Tanzania
      Ifakara Health Institute
    May 26, 2022

    Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5

    Recruiting
    • Plasmodium Falciparum Malaria
    • artemether:lumefantrine (2.5 mg:30 mg)
    • Nanoro, Burkina Faso
    • +5 more
    Nov 28, 2022

    Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

    Not yet recruiting
    • Malaria, Plasmodium Falciparum
    • Matrix-M with RH5.2 VLP and/or R21
    • (no location specified)
    Oct 21, 2022

    Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)

    Not yet recruiting
    • Plasmodium Falciparum Infection
    • Malaria
    • L9LS (VRC-MALMAB0114-00-AB)
    • Normal Saline
    • Faladje, Région De Koulikoro, Mali
    • +2 more
    Apr 17, 2023

    Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,

    Recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
    • +7 more
    Oct 7, 2023

    Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)

    Recruiting
    • Plasmodium Falciparum Infection
    • Malaria
    • Kisumu, Kenya
      Kenya Medical Research Institute (KEMRI) Center for Global Healt
    Sep 15, 2022

    Uncomplicated Plasmodium Falciparum Malaria Trial in Burkina Faso, Gabon, Mali (KAF156, LUM-SDF)

    Recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • Bobo Dioulasso, Burkina Faso
    • +4 more
    Jun 20, 2022

    Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

    Active, not recruiting
    • Plasmodium Falciparum Infection
    • Malaria
    • VRC-MALMAB0100-00-AB (CIS43LS)
    • Normal saline
    • Kalifabougou, Région De Koulikoro, Mali
    • +1 more
    Sep 20, 2022

    Malaria,Falciparum Trial in Leiden (biological, drug, other)

    Not yet recruiting
    • Malaria,Falciparum
    • GA2
    • +4 more
    • Leiden, Netherlands
      Leiden University Medical Center
    Jul 18, 2022

    Acute Malaria Trial in Worldwide (M5717 330 mg, M5717 500 mg, M5717 660 mg)

    Not yet recruiting
    • Acute Malaria
    • M5717 330 mg
    • +8 more
    • Nanoro, Burkina Faso
    • +4 more
    Jan 9, 2023

    Malaria Trial in Bamako (Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine))

    Active, not recruiting
    Has Results
    • Malaria
    • Pfs230D1M-EPA/AS01
    • +4 more
    • Bamako, Mali
      Mrtc/Usttb
    Jul 29, 2022